Quick Answer
LakeShore Biopharma Co., Ltd. reported Total Assets of $190.53 million for the year ending 2025.
- LakeShore Biopharma Co., Ltd. showed a decrease of -87.4% in Total Assets from 2024 to 2025.
- This data is from LakeShore Biopharma Co., Ltd.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), LakeShore Biopharma Co., Ltd.'s Total Assets has declined by 86.8%.
- Historical annual values: Fiscal year 2025: $190.53 million | Fiscal year 2024: $1.51 billion | Fiscal year 2023: $1.72 billion | Fiscal year 2022: $1.44 billion.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: